We did it! We are beyond excited to share some incredible news: our Safer Under The Sun initiative in Washington D.C. and sustained congressional advocacy have delivered results. On November 10, 2025, The Senate passed H.R. 5371, a major law that modernizes the OTC drug monograph system and transforms Sunscreen Regulation for the first time in decades.
dsm-firmenich, in partnership with Personal Care Products Council, recently testified before Congress urging modernized sunscreen standards to fight America’s fastest-growing cancer—Skin Cancer.
The testimony highlighted the slow FDA approval process, limited access to safe global UV filters, and proposed reforms under OMFU 2.0* to drive Sunscreen Innovation.
* Over-the-Counter Monograph Federal Uniformity.
Join us for a pivotal moment in photoprotection innovation!
Why This Webcast Matters
Dr. Jochen Klock
Senior Director, Global Regulatory Affairs
Beauty & Care, dsm-firmenich
Tina Vogt
Director, Global Marketing Sun Care
Beauty & Care, dsm-firmenich
Dr. Steven Q. Wang, M.D.
Chief of Dermatology,
Hoag Memorial Hospital Presbyterian Newport Beach CA
Carl D’Ruiz, MPH
Head of Beauty & Care Science,
Advocacy & Business Development, dsm-firmenich North America
Skin cancer is the most common form of cancer in the US, and is responsible for more than two deaths every hour (Centers for Disease Control and Prevention).
What’s more, rates of skin cancer are rising. But despite this, it’s been more than 25 years since a new UV filter was approved by the FDA.
dsm-firmenich is the first company to formally urge the FDA and Congress to accelerate the approval process. We continue not only to apply our deep regulatory expertise, but also to uphold our long-standing commitment to skin health advocacy. Through efforts like the Destination Healthy Skin program and the annual Safer Under the Sun Day in Washington D.C., dsm-firmenich is driving since years collaboration between industry and government to make advanced suncare accessible to all Americans.
Now, we’re on the brink of a breakthrough. dsm-firmenich is awaiting U.S. approval for PARSOL® Shield: the most efficient broadband UVB-UVA filter, now set to transform global skin protection.
Already approved outside America, this product will be available in the US upon FDA approval, expected in June 2026.
Our next-generation UV filter offers broad-spectrum, photostable protection, even at low concentrations. With excellent skin feel, microbiome friendliness, and a strong eco-profile, PARSOL® Shield is poised to set a new global benchmark for quality post-FDA approval.
“PARSOL® Shield is the next best thing”
Carl D'Ruiz - Business Development Manager
“PARSOL® Shield is a game changer”
Vicki Barboiu - Head of Beauty & Care
At dsm-firmenich, advocating for healthy skin is more than a mission; it’s a responsibility. For many years, we’ve been working to protect public health through our efforts like the Destination Healthy Skin program and the annual Safer Under the Sun Day in Washington DC.
And with the upcoming FDA approval of PARSOL® Shield, we’re setting a new benchmark in sun protection and public health.
As the first new sunscreen active to be approved in the US in over 25 years, PARSOL® Shield will represent a breakthrough in broad-spectrum UV protection. It will help to prevent skin cancer, as well as other sun-induced skin damage and premature aging.
Through our advocacy initiatives, our science-based tools, and our commitment to ethical innovation, we continue to champion safer sun exposure and empower consumers with next-generation protection.
PARSOL® Shield offers advanced photoprotection to support the prevention of skin cancer and help safeguard against sun-induced skin damage and premature photoaging.
In turn, our sunscreen active contributes to overall skin health and consumer well-being.
“Skin cancer is the most common cancer in the United States, with more than two deaths every hour.”
Source: Centers for Disease Control and Prevention
“One study found that regular daily use of sunscreen reduces the risk of developing melanoma by 50 percent, when used as directed.”
Source: Skin Cancer Facts & Statistics
“Having 5 or more sunburns doubles your risk for melanoma.”
Source: Skin Cancer Facts & Statistics
PARSOL® Shield (INCI: Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine) is a photostable broad-spectrum filter that efficiently contributes to UVB and UVA protection across the full range of application forms at low concentrations.
It demonstrates excellent compatibility with both organic and inorganic UV filters and is readily compatible with other PARSOL® UV filters. As part of a holistic formulation, PARSOL® Shield supports high levels of water resistance due to its good solubility in organic oils.
Microbiome-friendly UV filter independently certified by MyMicrobiome
PARSOL® Shield is on track to become the first new sunscreen active ingredient approved by the FDA in over 25 years. With its exceptional UVA-UVB performance at low concentrations, strong eco-profile, and microbiome compatibility, it’s set to redefine skin health and well-aging.
We’re giving you, our valued partner, the opportunity to evaluate this next-generation UV filter ahead of market adoption. Whether you're formulating high-performance sunscreens or looking to expand your global portfolio, PARSOL® Shield enables future-proof, science-based formulations aligned with evolving regulatory and consumer needs.
Discover the power of PARSOL® Shield through our state-of-the-art SUNSCREEN OPTIMIZER™, the perfect tool for supporting the creation of high-performance, sustainable suncare solutions.
Stay tuned for more news from the FDA soon!
PARSOL® TX (INCI: Titanium Dioxide, Silica, Dimethicone) is an inorganic UVB filter providing a very good SPF performance as well as a significant contribution to UVA protection into the blue light range.
PARSOL® Max (INCI: Methylene Bis-Benzotriazolyl Tetramethylbutylphenol) is a photostable broad spectrum UV filter which delivers outstanding performance that breaks through the boundaries of UVB and UVA to continue into the blue light spectrum.
PARSOL® 1789 (INCI: Butyl Methoxydibenzoylmethane) is a very strong and efficient UVA absorber for sunscreen and other skin care formulations. It enables broadband protection when combined with effective UVB filters and can also contribute to SPF.
PARSOL® ZX (INCI: Zinc Oxide, Triethoxycaprilylsilane) is an inorganic UV filter with a broad UVA‐UVB absorption curve that also goes into the blue light spectrum. Our grade with a particle size ensures SPF and best UVA performance.
Building on our strong expertise in application, dsm-firmenich formulators create desirable formulations that can be used in a variety of market applications.
Download a Safety Data Sheet (SDS) for this product.